Baxter International Inc. has initiated a voluntary nationwide recall of Lot LD175708 of Cefazolin in Dextrose Injection, USP. The recall is due to the discovery of particulate matter within the solution, impacting patient safety and regulatory compliance.
Baxter International Recalls Cefazolin in Dextrose Injection Due to Particulate Matter
BAXhealthcareproduct-recallpharmaceuticalscorporate-action
